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HISTOCOMPATIBILITY  ANTIGEN-ACTIVATED 
CYTOTOXIC  T  LYMPHOCYTES 
Estimates of the Absolute Frequency of Killer Cells Generated In 
Vitro* 
BY  KIRSTEN  FISCHER  LINDAHL$  AND  DARCY  B.  WILSON 
(From the Immunobwlogy Research Unit, Department of Pathology, Unwers~ty of Pennsylvanm 
School of Medicine, Phdadelphm,  Pennsylvanm 19174) 
Numerous  studies  of the  immunobiology of cytotoxic thymus-derived (T) 
lymphocytes (CTL)  1 have provided detailed information on both the induction 
and detection of CTL activity directed against alloantigen-bearing target cells 
(1). These studies have depended heavily on the availability of rapid cytolytic 
assays which involve the release of radioactive mCr from isotopically labeled 
target cells. While these methods have been employed to derive relative esti- 
mates of cytotoxic potency of various immune lymphocyte populations, this 
assay as currently used does not provide direct estimates of the absolute fre- 
quency of CTL in such populations. 
In a previous study the frequency of killer cells in a population of lymphocytes 
from the draining lymph nodes of immunized animals was estimated to be 
approximately 1-2%.  This figure was based  on limiting dilution of immune 
lymphocytes and  analysis of target  cell survival with an electronic particle 
counter  (2). There  were  certain  weaknesses  in  that  study:  (a)  it  involved 
relatively long assay periods (48 h), making it difficult to rule out that new killer 
cells were generated in the cultures; (b) the assumption that a killer cell could 
affect  only  a  single target  cell,  an  assumption which if not valid leads  to 
erroneously high estimates of CTL frequency; and (c) it could not be determined 
at the time whether killer cells were exclusively of thymic origin. 
In the present study, we describe another procedure which combines limiting 
dilution  and  '~'Cr release  for  deriving a  minimal estimate  of the  absolute 
frequency of CTL  generated in  mouse lymphocyte populations activated  to 
alloantigens of the major histocompatibility complex in bulk mixed lymphocyte 
cultures (MLC), some details of the specificity of CTL, as well as an estimate of 
the number of target cells killed by a single CTL. 
Materials and Methods 
M~ce  Mine of both sexes, 2-5 mo of age, were used.  B10.BR (H-2  k) were purchased from The 
Jackson Laboratory, Bar Harbor, Maine, while C3H/He  (H-2  ~), BALB/c (H-2d),  DBA/2 (H-2d), 
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' Abbrevmtmns  used  in th~s paper:  CTL,  cytotoxic T  lymphocytes;  HPBSS-2  and  HPBSS-5, 
Hanks' balanced salt solutmn supplemented with 2% and 5% fetal calf serum, respectively; MLC, 
mixed lymphocyte culture. 
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and C57BL/6 (H-2 b) were obtained from the Institute for Cancer Research, Fox Chase, Pa., and 
maintained in our colonies. 
Media.  Four different media were used. Before culture cells were washed in Hanks' balanced 
salt solution (powder; Microbiological Associates, Bethesda, Md.) buffered with i  mM phosphate, 
and supplemented with 2%  (vol/vol) fetal calf serum  (lot no.  88373;  Microbiological Associates) 
(HPBSS-2). Target cells were prepared and washed in the same medium but supplemented with 
5% (vol/vol) fetal calf serum which had been heated for 2 h  at 56°C  (HPBSS-5). Culture medium 
was  RPMI  1640  supplemented  with  12  mM  Hepes,  25%  (vol/vol) fetal  calf serum,  penicillin- 
streptomycin  (all from  Microbiological Associates),  2  mM  L-glutamine  (BDH  Chemicals Ltd., 
Poole, England), and 4 ×  10  -5 M 2-mercaptoethanol (Eastman Kodak Co., Rochester, N. Y.). The 
same medium was used for the cytotoxic assay,  except that it contained no 2-mercaptoethanol 
and only 10% (vol/vol) fetal calf serum which had been heat inactivated. 
In Vitro Immunization.  Lymphocytes were  stimulated with alloantigens in MLC  prepared 
from spleens or, where indicated, from lymph nodes. These organs were removed aseptically into 
HPBSS-2 and gently teased with forceps. Clumps were allowed to settle and the cells remaining in 
suspension were washed once by centrifugation at 130 g  for 8 rain in HPBSS-2. Viable cells were 
assessed by phase microscopy using eosin. The cells to be used as stimulators were irradiated 1,750 
R (110 R/rain) with a ~37Cs source. Mixed cultures were conducted in Falcon no. 3012 flasks (Falcon 
Plastics, Div. of BioQuest, Oxnard, Calif.) with 10 ×  10  s responding and 8 ×  106 stimulating cells 
in 4.5 ml culture medium (3). The cultures were incubated at 37°C in a humidified atmosphere of 
8%  CO2  in  air.  Cells  to  be  restimulated  were  collected  after  10  or  11  days  of culture  and 
resuspended in fresh medium, and I  ×  10  s viable cells were cultured with 8 ×  106 fresh stimulater 
cells as described above. 
Target Cells.  The DBA/2 mastocytoma, P815, obtained from Dr. C. S. Henney, Johns Hopkins 
University, Baltimore, Md.,  and maintained in ascites form by weekly passage,  was employed 
for cytotexicity assays 4-7 days after transfer. The tumor cells were washed once in HPBSS-5 at 
32 g  for 6 min. For labeling, 107 cells were incubated in 0.3 ml of RPMI 1640 with 25% fetal calf 
serum and 1-2 mCi 51Cr as sodium chromate  (10 mCi/ml,  approximately 250 mCi/mg Cr, New 
England  Nuclear,  Boston,  Mass.)  for  2  h  at  37°C.  Thereafter,  the  labeled  target  cells  were 
washed twice at 100 g  for 6 rain in HPBSS-5 before use in the assay.  In some experiments the 
target cells were incubated 0.5-1 h at 37°C before the last wash. Viable cells (usually >90%) were 
counted with eosin and diluted to 2  ×  103 cells/ml. 
Preliminary experiments indicated that the amount of 5~Cr taken up by the target cells was 
directly related to the concentration of the isotope and remained constant after 2 h of incubation. 
Each target cell contained 1.5-3 cpm releasable 5~Cr. The high concentration ofs~Cr did not appear 
to affect the spontaneous release or the ability of the target cells to be lysed; nor did the low 
concentration of target cells used in the cytotoxicity assay significantly affect spontaneous release 
values. In all experiments, spontaneous release ranged from 17.4 to 34.1% of the maximum release 
with a  median of 22.6%. 
Cytotoxicity Assay.  Immune  cells  were  collected  from  primary  MLC  on  day  5  and  from 
secondary cultures on day 3 after restimulation. The cells were suspended in assay medium and 
viable cells were assessed by phase-contrast microscopy using eosin dye. The assay was carried out 
in V-bottom microtiter plates (IS-MVC-96-TC; Linbro Scientific Company,  New Haven, Conn.); 
each well contained 0.1 ml of the desired dilution of immune cells in assay medium and 0.05 ml of 
labeled target cells (100 cells added per well). Each immune cell dose was tested in a minimum of 
24 wells, but usually in 48 or 96 wells. Target cells were also added to control wells containing 
medium alone, from which spontaneous release was determined, and to others containing 0.1 ml of 
3.5% (wt/vol) cetrimide (Fisher Scientific Co., Fair Lawn, N. J.), from which maximum release 
values were determined. 
Lids were then placed on the plates and they were spun at 20 g  for 5 min after which they were 
placed for 6 h at 37°C in a humidified incubator with an atmosphere of 8% CO2 in air. At the end of 
this incubation period,  0.05 ml of HPBSS-5 was added to each well with a  Hamilton repeating 
syringe (Arthur H.  Thomas Co.,  Philadelphia, Pa.),  and the plates were centrifuged at 1,000 g 
for 8 min. A constant volume of supernate was removed from each well, and the amount of 5~Cr 
released into the medium was determined by counting for 2 or 4 min in a  gamma spectrometer. 
Since the time required for counting an experiment was usually 2-3 days, groups of tubes were 
counted in order of increasing expected 51Cr release. Thereby the spontaneous release values are 
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groups with most killing. No further correction for radioactive decay was applied. 
In each experiment the cytotoxic activity of immune cells was also tested simultaneously in a 
standard assay containing 104 target cells and immune cell:target cell ratios ranging from 20:1 
down to 0.08:1 in triplicate. Plots of percent specific ~'Cr release as a function of the dose of effector 
cells from each experiment were superimposable. Plateau levels of 60-100% specific ~'Cr release 
were reached in 6 h  at a  ratio of five immune cells per target cell. 
Results 
Detection  of  Cytotoxicity  With  Low  Numbers  of  Immune  Lympho- 
cytes.  Detection of cytotoxic activity caused by very low numbers of immune 
lymphocytes requires an assay sensitive enough to reveal the lysis of small 
numbers of target cells; i.e., the killing of as few target cells as possible should 
represent 51Cr release values significantly above  spontaneous release levels. 
With the labeling procedure adopted, as few as 100 target cells contained enough 
radioactivity to allow quantitation of released label with conventional gamma 
spectrometry, and under these conditions, the killing of 18 target cells in 6 h 
represented a value three standard deviations above the mean of spontaneous 
release. 
Fig. 1 shows the effect of adding limiting dilutions of immune lymphocytes to 
100  highly labeled target cells.  With 10 immune cells, the overall frequency 
distribution  of '~'Cr release  is  not  significantly  different from  spontaneous 
release, thus setting an upper limit of 1 per 10 to the frequency of cytotoxic cells. 
However, in a  few wells with 10 immune cells,  the '~'Cr release was clearly 
different from the  spontaneous  release.  With  30  immune cells,  the  overall 
frequency distribution differed significantly. 
It  is  clear that  as  the  number of cells  increases,  ~'Cr-release values  also 
increase.  However, rather than becoming a  biphasic  distribution  with some 
wells clearly negative and others clearly positive, the whole distribution shifted 
toward higher mCr release. This suggests that the number of target cells killed 
by each CTL  varies over a  wide range.  As there was no clear demarcation 
between negative and positive wells, we arbitrarily defined as positive those 
wells in which mCr release exceeded three standard deviations above the mean 
of the spontaneous release value. This is a conservative estimate which reduces 
the probability of false positives to less than 0.14%, and the killer cell frequency 
obtained must therefore be considered to be a minimal estimate. 
Frequency  of CTL  in Immune  Lymphocyte  Populations.  Semilogarithmic 
plots  of the fraction of negative wells as  a  function of the dose of immune 
lymphocytes displayed a linear relationship with an intercept on the ordinate of 
1.0 (Fig. 2). This is consistent with previous conclusions of others (2, 4-6) that 
cell-mediated cytotoxicity is the outcome of a  single cell event. It follows from 
the Poisson distribution that the dose of cells which give 37%  negative wells 
contains, on the average, a single CTL (7). MLC-activated H-2  k anti-H-2 ~ spleen 
cells contain a  minimum of 1 CTL per 82-127  cells specific for H-2 d targets, 
whereas 17,000-40,000  similarly activated H-2 ~ anti-H-2  ~ cells are required to 
provide similar activity on H-2 ~ targets. 
Table I summarizes all of our experiments of this type in which various strain 
combinations, spleen- and lymph node-responding cells, the effect of restimula- 
tion, and the killing of cross-reactive targets is compared. Part A shows that (a) R  fj]l  (11  MR  ,I. 
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FIG.  1.  Frequency distribution ofs'Cr release from wells with various numbers of immune 
lymphocytes added to 100 P815 target cells. Spontaneous release (SR) with medium alone 
and maximum release  (MR) in the presence of cetrimide are indicated in the top panel. 
Second to fifth panels, C3H anti-DBA/2; bottom panel, DBA/2 anti-C3H. The mean of each 
distribution is indicated by an arrow. The vertical line indicates three standard deviations 
above the mean of spontaneous release values; wells plotted to the right of this line are 
considered positive, while wells plotted to the left are considered negative. 
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FIG.  2.  Results of Fig.  1 and two similar experiments plotted as the fraction of negative 
wells vs. the dose of immune lymphocytes. C3H anti-DBA/2 (I); B10.BR anti-BALB/c (i, 
O); DBA/2 anti-C3H  ([2);  and BALB/c anti-B10.BR (A,  O),  all tested on 100 P815 target 
cells. The lines were fitted by the least squares method. 
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TABLE  I 
A. CTL frequency  in immune lymphocyte populations  B. Average rate of killing 
(no. of targetslCTL  hour) 
Exp.  Responder  Stimulater  No. CTL per .  n*  r25  Cell yield§  102 IC~' 102  103 IC, 102  1.25 ×  104 
100 cells  mtercept  TC  TC  IC, 104 TC 
% 
1  B10.BR spleen  BALB/c spleen  1.17  1.065  4  0.950  51  3.25 
BALB/c  B10.BR  0.006  0.876  4  0.816  54 
2  B10.BR  BALB/c  0.79  0.911  4  0.946  74  4.09 
BALB/c  B10.BR  0.003  0.965  4  0.783  50 
3  C3H  DBA/2  0.88  1.187  4  0.995  67  4.24 
DBA/2  C3H  0.005  1.033  4  0.262  41 
BALB/c  DBA/2  0.003  1.061  4  0.067  40 
4  C3H anti-DBA/2¶  DBA/2  1.07  1.298  5  0.982  242  3.56 
5  C3H anti-DBA/2  DBA/2  1.08  1.146  4  0.964  350  3.34 
C3H  0.16  1.087  3  0.995  125  1.92 
6  C3H LN  DBA/2 spleen  0.72  1.292  4  0.983  128  3.41 
C57BL/6  0.07  1.068  5  0.953  118  - 
7  C3H LN  DBA/2  0.70  1.424  4  0.933  117  1.80 






2.62  6.44 
3.52 
4.51  11.65 
2.15 
3.69  8.63 
* n, number ef  points en the regressien line. 
r  2, coefficient  ef  determination. 
§ Number of  immune cells  recovered from the cultures as a percentage  of  the initial  number of  responding  cells. 
4~ IC, immune cells;  TC, target cells. 
¶ Immune cells  were primed in vitro  for 10 (exp. 4) er 11 days (exp. 5);  the cells  were tested 3 days after  restimulation (see  Materials and 
Methods). 
the frequency of CTL in all of the specifically activated immune lymphocyte 
populations tested ranged from 0.7 to 1.2%; (b) there was no difference in the 
frequency of CTL in activated lymph node and splenic lymphocyte populations, 
although the cell yield was twofold higher using lymph node lymphocytes as 
responding cells; (c) despite a higher yield and an earlier response in restimu- 
lated cultures, the frequency of CTL was the same as that generated in primary 
cultures; and (d)H-2  k anti-H-2  b lymphocytes, having normal activity on specific 
targets  (data not shown) were only one-tenth as active on cross-reactive H-2  ~ 
targets in comparison to H-2  k anti-H-2  '~ immune cells. It must be re-emphasized 
that  these  CTL  frequencies  are  minimal  estimates;  it  is  possible  that  the 
frequency  of cross-reactive  CTL  is  higher,  and  that  each  has  less  cytolytic 
activity. 
Rate of  KiUing in Cell-Mediated Cytotoxicity.  The rate of  51Cr release proved 
to be constant over the 6-h assay period at any given dose of immune cells. Given 
an estimate of the minimal frequency of CTL it is therefore possible to derive a 
maximal  estimate  of the average  rate  of target  cell killing  (i.e.,  counts per 
minute above spontaneous release/counts per minute per target cell/estimated 
number of CTL per well/hours of culture).  As shown in Table II, the average 
rates of killing were comparable in the assay systems which employed 102 and 
104  target  cells.  The  rapid decrease  in the  rate  of killing  as the number  of 
immune cells increases probably reflects a decreased frequency of meaningful 
collisions between effector and target cells  caused by  increasing  numbers  of 
"bystander" lymphocytes. KIRSTEN  FISCHER  LINDAHL  AND  DARCY  B.  WILSON 
TABLE  II 
Average Rate of Killing at Different Doses of Immune Cells 
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10  2 Target cells  10  4 Target cells 
No. ofimmune  cells Targets killed/CTL/ 
hour 
No. ofimmune cells  Targets killed/CTL/ 
hour 
10  2.10  7.8  x  102  19.31 
30  5.13  31.3  x  102  10.98 
100  4.24  125  x  102  4.99 
300  2.19  500  x  102  1.62 
1,000  0.67  2,000 x  102  0.42 
Results of  experiment shown in  Figs. i  and 2  in  which there was an average of  i  CTL 
per 113.4  immune cells. 
Table I, part B shows the results from all our experiments, giving the rates of 
killing at ratios of 1 immune cell per target cell or 1 CTL per 100 target cells. The 
killing rates vary over the range 1.8 to 11.65 targets/CTL/hour with a median of 
4 targets/CTL/hour, and they are comparable for lymph node and spleen cells, as 
well as for restimulated cells. 
Discussion 
The present study combines the sensitivities of a limiting dilution procedure 
for immune cells and of~lCr release from highly labeled target cells to derive an 
estimate of CTL frequency  in a population of mouse lymphocytes  activated to H- 
2 alloantigens in bulk MLC.  Using this assay procedure, we showed that (a) 
between 0.7 and 1.2% of surviving cells in an MLC-activated population are 
cytolytically  active (Fig.  2, Table I), and (b) from this CTL frequency estimate, 
the maximal rate of target cell killing at immune cell:target cell ratios of 1:1 
could be calculated to be 4 targets/CTL/hour (Tables I and II). These conclusions 
rest on the single assumption that significant 5'Cr release can be caused by a 
single killer cell. This assumption could not be verified experimentally since the 
frequency distribution was not biphasic, showing clearly positive and negative 
wells (Fig.  1). Therefore, it must be re-emphasized that the estimates of CTL 
frequency provided are  minimal;  clearly more  CTL  could  be  present,  each 
causing less 51Cr release. 
Our estimate that 1% of an MLC-activated lymphocyte population are killer 
cells  is  consistent with  previous  studies  of CTL  frequencies.  Golstein  and 
Blomgren (8) demonstrated that as few as 103 highly purified T lymphocytes 
from an educated thymus cell population displayed significant cytotoxic activ- 
ity. Moreover, with a recently developed plaque assay for cytotoxic cells it was 
found that between 0.05 and 2% of the cells were active in alloimmune lympho- 
cyte preparations (9). Wilson (2) and Henney (4), employing  the assumption that 
cytolytically active cells undergo only one round killing,  suggested that the 
frequency of killer cells present in lymphocyte populations obtained from an 
immune animal may be as high as 1-4%. Several studies have recently appeared 
in which immune lymphocytes  are allowed to interact only once with target cells 
and form complexes, and the CTL frequency is then estimated from the fre- 
quency of complexes and  the  resulting  number of target  cells  killed.  The 506  FREQUENCY  OF  CYTOTOXIC T  LYMPHOCYTES 
estimates of the frequency of CTL range from 0.7 to 2.2% (10) to 6 to 10% (11) in 
the spleen and from 6  (6) to 35%  (11) among peritoneal  exudate lymphocytes 
from immune donors. 
CTL frequencies obtained with MLC-activated lymphocyte populations do not 
necessarily reflect the total activity that can be obtained with other procedures 
of sensitization. Thus the very high frequency of CTL among peritoneal exudate 
lymphocytes probably reflects both the comparative efficiency of in vivo sensiti- 
zation  and  the  selective  migration  of activated  cells  to  a  peritoneal  site  of 
inflammation. 
Knowledge of the absolute frequency of CTL in a  given immune lymphocyte 
population is important  in establishing two other parameters of cell-mediated 
cytotoxicity. Firstly, the average number of target cells killed by a single CTL 
during the assay period can be calculated. The killing rate thus obtained (Tables 
I  and  II)  is  consistent  with  estimates  provided  from direct  observations  (5). 
Secondly, from the absolute frequency of CTL and of precursors of CTL,  it is 
possible to obtain estimates  of average  clone size after activation  of a  single 
precursor,  as described in the accompanying paper (12). 
Summary 
A  sensitive procedure employing limiting dilution of activated lymphocytes 
and 51Cr release from highly  labeled target  cells was used to derive minimal 
estimates of the absolute frequency of cytotoxic T lymphocytes (CTL) present in 
a  population  of mouse  lymphocytes  activated  to  alloantigens  of the  major 
histocompatibility complex in bulk mixed lymphocyte cultures. From this figure 
(0.7-1.2%),  the  maximal  rate  of target  cell killing  could be calculated  to be 
approximately 4 targets/CTL/hour. 
We thank Dr. Jonathan C. Howard for fruitful discussions, and Ms. D. H. Wilson for preparation 
of the figures. 
Received for publication  8 November 1976. 
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